[Review] Biological therapies for rheumatoid arthritis: An overview for the clinician
Loading...
Date
Authors
Findeisen, Kate E
Sewell, Julia
Ostor, Andrew
Journal Title
Journal ISSN
Volume Title
Publisher
Dove Medical Press Ltd
Abstract
Rheumatoid arthritis (RA) is a disease characterised by inflammation of synovial joints and poses a substantial healthcare burden on both the individual and society. One of the most significant shifts in the RA therapeutic landscape has occurred with the introduction of biological disease modifying anti-rheumatic drugs (bDMARDs). There are five classes of bDMARDs currently available, each with a different molecular target and subtle differences in their efficacy and safety profile. This review also describes the “real-world” use of bDMARDs and how they fit into the overall RA treatment guidelines.
Description
Keywords
Citation
Collections
Source
Biologics: Targets and Therapy
Type
Book Title
Entity type
Access Statement
Open Access
License Rights
Creative Commons Attribution licence